Acute Lymphoblastic Leukemia: Risk Stratification
1 ビュー
administrator
06/15/23
Mark R. Litzow, MD; Ryan D. Cassaday, MD; Aaron C. Logan, MD, PhD; Bijal D. Shah, MD; and Anthony S. Stein, MD, reflect on the complexities of the risk stratification process in acute lymphoblastic leukemia, incorporating patient age, molecular subtype, and minimal residual disease status.
もっと見せる
フェイスブックのコメント
コメントがありません